No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs2685810 |
chr2:169797732-169797733 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs542120968 |
chr2:169797816-169797817 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs548250948 |
chr2:169797826-169797827 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs4516393 |
chr2:169797878-169797879 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs530646987 |
chr2:169797887-169797888 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs2685811 |
chr2:169797927-169797928 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
7 |
rs569920126 |
chr2:169798014-169798015 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs79609490 |
chr2:169798015-169798016 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs77601801 |
chr2:169798033-169798034 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs115233753 |
chr2:169798079-169798080 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs534738110 |
chr2:169798108-169798109 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs546737866 |
chr2:169798144-169798145 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs78386555 |
chr2:169798150-169798151 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs140801079 |
chr2:169798159-169798160 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs192235002 |
chr2:169798168-169798169 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs2685812 |
chr2:169798171-169798172 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
17 |
rs557279018 |
chr2:169798188-169798189 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs183405292 |
chr2:169798189-169798190 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs150443370 |
chr2:169798239-169798240 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs546111037 |
chr2:169798269-169798270 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs187616460 |
chr2:169798279-169798280 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs192190298 |
chr2:169798308-169798309 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs73016694 |
chr2:169798315-169798316 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
24 |
rs77913588 |
chr2:169798363-169798364 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs184185831 |
chr2:169798426-169798427 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs530477217 |
chr2:169798431-169798432 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs2685813 |
chr2:169798439-169798440 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
28 |
rs563533781 |
chr2:169798555-169798556 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs2685814 |
chr2:169798619-169798620 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
30 |
rs552433423 |
chr2:169798636-169798637 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs566002137 |
chr2:169798637-169798638 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs535339554 |
chr2:169798652-169798653 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs138421062 |
chr2:169798703-169798704 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs35384412 |
chr2:169798713-169798714 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs568443297 |
chr2:169798724-169798725 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs3084063 |
chr2:169798732-169798733 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs200248646 |
chr2:169798735-169798736 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs71003065 |
chr2:169798736-169798737 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs2216503 |
chr2:169798737-169798738 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs78505070 |
chr2:169798739-169798740 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs187090528 |
chr2:169798743-169798744 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs373975082 |
chr2:169798789-169798790 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs537145726 |
chr2:169798808-169798809 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs557530621 |
chr2:169798815-169798816 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs13407637 |
chr2:169798850-169798851 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs571530409 |
chr2:169798885-169798886 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs577095623 |
chr2:169798923-169798924 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs534153214 |
chr2:169798970-169798971 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs539671967 |
chr2:169798975-169798976 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs6709087 |
chr2:169799010-169799011 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|